Compass Therapeutics OverviewCompass Therapeutics Other Income Expense Net
Other Income/Expense Net for CMPX.
Quarterly Other Income/Expense
$1.98M
↑ 48.69% YoY
As of Mar 31, 2026
Annual Other Income/Expense (TTM)
$3.17M
↓ 52.02% YoY
Trailing 12 months ending Mar 31, 2026